Systematic Review

Published on 16 Jul 2024

Metabolic reprogramming in hepatocellular carcinoma: a bibliometric and visualized study from 2011 to 2023

in Pharmacology of Anti-Cancer Drugs

Xia Li
Liping Zhou
Xinyi Xu
Xiyang Liu
Wenjun Wu
Quansheng Feng
Ziwei Tang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1392241

1,446 views

Original Research

Published on 15 Jul 2024

Superior cuproptotic efficacy of diethyldithiocarbamate-Cu4O3 nanoparticles over diethyldithiocarbamate-Cu2O nanoparticles in metastatic hepatocellular carcinoma

in Pharmacology of Anti-Cancer Drugs

Marwa M. Abu-Serie
Assem Barakat
Sherif Ramadan
Noha Hassan Habashy

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1388038

1,520 views

Systematic Review

Published on 12 Jul 2024

Trend of albumin nanoparticles in oncology: a bibliometric analysis of research progress and prospects

in Pharmacology of Anti-Cancer Drugs

Ye Liu
Yi Li
Wei Shen
Min Li
Wen Wang
Xin Jin

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1409163

1,273 views

Original Research

Published on 11 Jul 2024

Hyaluronic acid-modified liposomes Potentiated in-vivo anti-hepatocellular carcinoma of icaritin

in Pharmacology of Anti-Cancer Drugs

Xiaoduan Sun
Zhenzhen He
Ruilin Lu
Zhongbing Liu
Sawitree Chiampanichayakul
Songyot Anuchapreeda
Jun Jiang
Singkome Tima
Zhirong Zhong

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1437515

1,368 views

Systematic Review

Published on 10 Jul 2024

Efficacy and safety of first- versus second-generation Bruton tyrosine kinase inhibitors in chronic lymphocytic leukemia: a systematic review and meta-analysis

in Pharmacology of Anti-Cancer Drugs

Liyuan Ke
Su Li
Danxue Huang
Yan Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1413985

963 views

Original Research

Published on 09 Jul 2024

Neurological adverse events associated with oxaliplatin: A pharmacovigilance analysis based on FDA adverse event reporting system

in Pharmacology of Anti-Cancer Drugs

Xianglin Pan
Xiangtian Xiao
Yiling Ding
Yamin Shu
Wenting Zhang
Liu Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1431579

1,241 views

Original Research

Published on 09 Jul 2024

Sponge-derived alkaloid AP-7 as a sensitizer to cisplatin in the treatment of multidrug-resistant NSCLC via Chk1-dependent mechanisms

in Pharmacology of Anti-Cancer Drugs

Li Guan
Ya-Hui Liao
Meng-Xue Cao
Li-Yun Liu
Hai-Tao Xue
Hong-Rui Zhu
Chang-Hao Bian
Fan Yang
Hou-Wen Lin
Hong-Ze Liao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1423684

864 views

Correction

Published on 08 Jul 2024

Corrigendum: Cinnamaldehyde suppressed EGF-induced EMT process and inhibits ovarian cancer progression through PI3K/AKT pathway

in Pharmacology of Anti-Cancer Drugs

Yue Wang
Ying Li
Liang Wang
Buze Chen
Miaolin Zhu
Chunyi Ma
Chunyan Mu
Aibin Tao
Shibao Li
Lan Luo

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1427330

531 views

Original Research

Published on 05 Jul 2024

Inhibition of NNMT enhances drug sensitivity in lung cancer cells through mediation of autophagy

in Pharmacology of Anti-Cancer Drugs

Jian Wang
Ming Zhang
Xin You
Yang Xu
Congcong Zhang
Ying Li
Chunhui Yang
Qi Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1415310

1,275 views

Review

Published on 05 Jul 2024

Network pharmacology: an efficient but underutilized approach in oral, head and neck cancer therapy—a review

in Pharmacology of Anti-Cancer Drugs

Pandiyan Muthuramalingam
Rajendran Jeyasri
Venkatramanan Varadharajan
Arumugam Priya
Anand Raj Dhanapal
Hyunsuk Shin
Muthu Thiruvengadam
Manikandan Ramesh
Murugesan Krishnan
Rebecca Oziohu Omosimua

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1410942

1,578 views

Review

Published on 04 Jul 2024

All-trans retinoic acid in hematologic disorders: not just acute promyelocytic leukemia

in Pharmacology of Anti-Cancer Drugs

Yan Chen
Xia Tong
Rongyuan Lu
Zhengfu Zhang
Tao Ma

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1404092

1,788 views
1 citation

Mini Review

Published on 04 Jul 2024

Mitochondrial inhibitors: a new horizon in breast cancer therapy

in Pharmacology of Anti-Cancer Drugs

Yalan Yan
Sijie Li
Lanqian Su
Xinrui Tang
Xiaoyan Chen
Xiang Gu
Guanhu Yang
Hao Chi
Shangke Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1421905

1,230 views
1 citation

Brief Research Report

Published on 03 Jul 2024

Targeting z-Crystallin by aspirin restores the sensitivity to cisplatin in resistant A2780 ovarian cancer cells

in Pharmacology of Anti-Cancer Drugs

Matteo Lulli
Andrea Trabocchi
Giandomenico Roviello
Martina Catalano
Laura Papucci
Astrid Parenti
Alice Molli
Cristina Napoli
Ida Landini
Nicola Schiavone

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1377028

978 views

Review

Published on 03 Jul 2024

Breaking the barrier: Nanoparticle-enhanced radiotherapy as the new vanguard in brain tumor treatment

in Pharmacology of Anti-Cancer Drugs

Shi feng Liu
Meng Jiao Li
Bing Liang
Wenshe Sun
Yingchun Shao
Xiaokun Hu
Dongming Xing

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1394816

1,044 views
1 citation

Perspective

Published on 01 Jul 2024

Lipid droplets: a candidate new research field for epithelial ovarian cancer

in Pharmacology of Anti-Cancer Drugs

Shiro Koizume
Tomoko Takahashi
Yohei Miyagi

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1437161

909 views

Original Research

Published on 01 Jul 2024

Infection associated with CDK4/6 inhibitors: a pharmacovigilance analysis of the FDA adverse event reporting system database

in Pharmacology of Anti-Cancer Drugs

Jinhua Chen
Linlin Tang
Wenping Song
Cuicui Sun
Wenzhou Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1371346

1,416 views

Navigation group

Articles

Metabolic reprogramming in hepatocellular carcinoma: a bibliometric and visualized study from 2011 to 2023

Superior cuproptotic efficacy of diethyldithiocarbamate-Cu4O3 nanoparticles over diethyldithiocarbamate-Cu2O nanoparticles in metastatic hepatocellular carcinoma

Trend of albumin nanoparticles in oncology: a bibliometric analysis of research progress and prospects

Hyaluronic acid-modified liposomes Potentiated in-vivo anti-hepatocellular carcinoma of icaritin

Efficacy and safety of first- versus second-generation Bruton tyrosine kinase inhibitors in chronic lymphocytic leukemia: a systematic review and meta-analysis

Neurological adverse events associated with oxaliplatin: A pharmacovigilance analysis based on FDA adverse event reporting system

Sponge-derived alkaloid AP-7 as a sensitizer to cisplatin in the treatment of multidrug-resistant NSCLC via Chk1-dependent mechanisms

Corrigendum: Cinnamaldehyde suppressed EGF-induced EMT process and inhibits ovarian cancer progression through PI3K/AKT pathway

Inhibition of NNMT enhances drug sensitivity in lung cancer cells through mediation of autophagy

Network pharmacology: an efficient but underutilized approach in oral, head and neck cancer therapy—a review

All-trans retinoic acid in hematologic disorders: not just acute promyelocytic leukemia

Mitochondrial inhibitors: a new horizon in breast cancer therapy

Targeting z-Crystallin by aspirin restores the sensitivity to cisplatin in resistant A2780 ovarian cancer cells

Breaking the barrier: Nanoparticle-enhanced radiotherapy as the new vanguard in brain tumor treatment

Lipid droplets: a candidate new research field for epithelial ovarian cancer

Infection associated with CDK4/6 inhibitors: a pharmacovigilance analysis of the FDA adverse event reporting system database